In Silico #001

​Recent advancements in computation are transforming the biomolecular sciences - from fine simulations of molecular structure and drug discovery, to coarse-grained systems analysis of complex biochemical, metabolic, or genetic networks. We can now accomplish in days what once took large teams of chemists and biologists months to design.

​Join us to discuss the future of biology and drug development with flash talks from:

• ​Saro Passaro (MIT): “Boltz-2: towards accurate and efficient binding affinity prediction”

• ​Jude Wells (UCL): "Plixer: generating drug-like molecules to fit protein pockets"

• ​Barney Hill (Oxford): “OligoScan: accelerating preclinical screening for rare disease gene therapies”

• ​Michaela Brezinova (Cambridge): "Identification of high-affinity secondary nucleation inhibitors of Aβ42 aggregation from an ultra-large chemical library using Deep Docking"

​Sponsored by londonmicrogrants.org